Youngy Health Co Ltd (300247) - Net Assets
Based on the latest financial reports, Youngy Health Co Ltd (300247) has net assets worth CN¥1.23 Billion CNY (≈ $179.92 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.48 Billion ≈ $217.10 Million USD) and total liabilities (CN¥254.09 Million ≈ $37.18 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Youngy Health Co Ltd's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.23 Billion |
| % of Total Assets | 82.87% |
| Annual Growth Rate | 22.88% |
| 5-Year Change | 37.35% |
| 10-Year Change | -19.04% |
| Growth Volatility | 64.26 |
Youngy Health Co Ltd - Net Assets Trend (2006–2024)
This chart illustrates how Youngy Health Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Youngy Health Co Ltd (300247) total assets for the complete picture of this company's asset base.
Annual Net Assets for Youngy Health Co Ltd (2006–2024)
The table below shows the annual net assets of Youngy Health Co Ltd from 2006 to 2024. For live valuation and market cap data, see market cap of Youngy Health Co Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.14 Billion ≈ $167.08 Million |
+6.44% |
| 2023-12-31 | CN¥1.07 Billion ≈ $156.97 Million |
+4.27% |
| 2022-12-31 | CN¥1.03 Billion ≈ $150.54 Million |
+19.47% |
| 2021-12-31 | CN¥861.11 Million ≈ $126.01 Million |
+3.59% |
| 2020-12-31 | CN¥831.31 Million ≈ $121.65 Million |
-6.65% |
| 2019-12-31 | CN¥890.52 Million ≈ $130.31 Million |
-44.38% |
| 2018-12-31 | CN¥1.60 Billion ≈ $234.31 Million |
-32.06% |
| 2017-12-31 | CN¥2.36 Billion ≈ $344.89 Million |
+3.93% |
| 2016-12-31 | CN¥2.27 Billion ≈ $331.84 Million |
+60.80% |
| 2015-12-31 | CN¥1.41 Billion ≈ $206.37 Million |
+108.65% |
| 2014-12-31 | CN¥675.89 Million ≈ $98.90 Million |
+15.30% |
| 2013-12-31 | CN¥586.22 Million ≈ $85.78 Million |
+3.07% |
| 2012-12-31 | CN¥568.73 Million ≈ $83.22 Million |
-0.36% |
| 2011-12-31 | CN¥570.81 Million ≈ $83.53 Million |
+150.37% |
| 2010-12-31 | CN¥227.98 Million ≈ $33.36 Million |
+49.43% |
| 2009-12-31 | CN¥152.57 Million ≈ $22.33 Million |
+30.45% |
| 2008-12-31 | CN¥116.96 Million ≈ $17.11 Million |
+29.22% |
| 2007-12-31 | CN¥90.51 Million ≈ $13.24 Million |
+223.46% |
| 2006-12-31 | CN¥27.98 Million ≈ $4.09 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Youngy Health Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5651.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CN¥804.04 Million | 75.45% |
| Other Components | CN¥1.41 Billion | 132.77% |
| Total Equity | CN¥1.07 Billion | 100.00% |
Youngy Health Co Ltd Competitors by Market Cap
The table below lists competitors of Youngy Health Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jereissati Participações S.A.
SA:IGTI3
|
$503.75 Million |
|
ForFarmers NV
AS:FFARM
|
$503.79 Million |
|
Aprogen Pharmaceuticals Inc
KO:003060
|
$503.85 Million |
|
GHCL Limited
NSE:GHCL
|
$503.88 Million |
|
Lutian Machinery Co Ltd
SHG:605259
|
$503.52 Million |
|
Zhejiang Zhe Kuang Heavy Industry
SHE:300837
|
$503.41 Million |
|
Guangdong Huiyun Titanium Industry
SHE:300891
|
$503.39 Million |
|
Jiangsu Apon Medical Technology Co Ltd Class A
SHE:300753
|
$503.17 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Youngy Health Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,016,847,716 to 1,065,690,539, a change of 48,842,823 (4.8%).
- Net income of 46,854,048 contributed positively to equity growth.
- Other comprehensive income decreased equity by 67,777,563.
- Other factors increased equity by 69,766,338.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥46.85 Million | +4.4% |
| Other Comprehensive Income | CN¥-67.78 Million | -6.36% |
| Other Changes | CN¥69.77 Million | +6.55% |
| Total Change | CN¥- | 4.80% |
Book Value vs Market Value Analysis
This analysis compares Youngy Health Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.23x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 34.49x to 3.23x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-12-31 | CN¥0.12 | CN¥4.28 | x |
| 2007-12-31 | CN¥0.37 | CN¥4.28 | x |
| 2008-12-31 | CN¥0.35 | CN¥4.28 | x |
| 2009-12-31 | CN¥0.45 | CN¥4.28 | x |
| 2010-12-31 | CN¥0.63 | CN¥4.28 | x |
| 2011-12-31 | CN¥1.37 | CN¥4.28 | x |
| 2012-12-31 | CN¥1.17 | CN¥4.28 | x |
| 2013-12-31 | CN¥1.19 | CN¥4.28 | x |
| 2014-12-31 | CN¥1.21 | CN¥4.28 | x |
| 2015-12-31 | CN¥2.73 | CN¥4.28 | x |
| 2016-12-31 | CN¥3.15 | CN¥4.28 | x |
| 2017-12-31 | CN¥3.10 | CN¥4.28 | x |
| 2018-12-31 | CN¥2.01 | CN¥4.28 | x |
| 2019-12-31 | CN¥1.09 | CN¥4.28 | x |
| 2020-12-31 | CN¥1.01 | CN¥4.28 | x |
| 2021-12-31 | CN¥1.03 | CN¥4.28 | x |
| 2022-12-31 | CN¥1.23 | CN¥4.28 | x |
| 2023-12-31 | CN¥1.15 | CN¥4.28 | x |
| 2024-12-31 | CN¥1.33 | CN¥4.28 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Youngy Health Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.40%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.80%
- • Asset Turnover: 0.53x
- • Equity Multiplier: 1.22x
- Recent ROE (4.40%) is above the historical average (2.06%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 45.67% | 13.77% | 1.35x | 2.46x | CN¥9.91 Million |
| 2007 | 18.28% | 15.56% | 0.79x | 1.48x | CN¥7.48 Million |
| 2008 | 22.66% | 18.35% | 0.96x | 1.29x | CN¥14.78 Million |
| 2009 | 23.47% | 21.00% | 0.90x | 1.24x | CN¥20.56 Million |
| 2010 | 19.92% | 23.10% | 0.74x | 1.17x | CN¥22.61 Million |
| 2011 | 8.14% | 22.41% | 0.35x | 1.04x | CN¥-10.60 Million |
| 2012 | 3.41% | 7.86% | 0.38x | 1.13x | CN¥-37.25 Million |
| 2013 | 2.78% | 6.12% | 0.40x | 1.15x | CN¥-42.01 Million |
| 2014 | 2.89% | 6.84% | 0.36x | 1.19x | CN¥-47.74 Million |
| 2015 | 2.93% | 9.51% | 0.23x | 1.35x | CN¥-98.31 Million |
| 2016 | 3.39% | 12.68% | 0.22x | 1.24x | CN¥-148.72 Million |
| 2017 | 2.12% | 4.06% | 0.41x | 1.27x | CN¥-184.04 Million |
| 2018 | -49.31% | -73.56% | 0.53x | 1.27x | CN¥-940.80 Million |
| 2019 | -81.72% | -98.07% | 0.64x | 1.29x | CN¥-803.68 Million |
| 2020 | -8.13% | -12.79% | 0.54x | 1.18x | CN¥-146.56 Million |
| 2021 | 2.91% | 4.60% | 0.52x | 1.23x | CN¥-58.94 Million |
| 2022 | 12.77% | 27.26% | 0.39x | 1.20x | CN¥27.41 Million |
| 2023 | 2.61% | 5.02% | 0.43x | 1.20x | CN¥-75.10 Million |
| 2024 | 4.40% | 6.80% | 0.53x | 1.22x | CN¥-59.72 Million |
Industry Comparison
This section compares Youngy Health Co Ltd's net assets metrics with peer companies in the Furnishings, Fixtures & Appliances industry.
Industry Context
- Industry: Furnishings, Fixtures & Appliances
- Average net assets among peers: $21,905,636,868
- Average return on equity (ROE) among peers: 14.16%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Youngy Health Co Ltd (300247) | CN¥1.23 Billion | 45.67% | 0.21x | $503.57 Million |
| Midea Group Co Ltd (000333) | $107.50 Billion | 22.52% | 1.81x | $82.47 Billion |
| Changhong Meiling Co Ltd (000521) | $879.37 Million | 0.76% | 1.77x | $730.28 Million |
| Gree Electric Appliances Inc of Zhuhai (000651) | $107.93 Billion | 21.37% | 1.96x | $32.83 Billion |
| Hisense Kelon Electrical Holdings Co Ltd (000921) | $-842.15 Million | 0.00% | 0.00x | $3.25 Billion |
| Suncha Technology Co Ltd (001211) | $929.64 Million | 7.56% | 0.38x | $439.66 Million |
| Elec-Tech International Co Ltd (002005) | $114.44 Million | 40.36% | 2.94x | $741.10 Million |
| Zhejiang Supor Co Ltd (002032) | $905.66 Million | 11.04% | 0.85x | $5.52 Billion |
| Vatti Corp Ltd (002035) | $112.32 Million | 31.19% | 1.62x | $730.59 Million |
| CNlight Co Ltd (002076) | $388.80 Million | 2.76% | 0.26x | $355.44 Million |
| Guangzhou Seagull Kitchen And Bath Products Co Ltd (002084) | $1.15 Billion | 4.02% | 0.60x | $364.92 Million |
About Youngy Health Co Ltd
Youngy Health Co., Ltd. engages in the manufacture, export, and sale of sauna products in China. Its products include traditional, foot, portable steam, and infrared sauna products, as well as air purifiers. The company also offers carbon heating painting products, functional sofas and chairs, saunalux, and SUP and boat products. It exports its products. The company was founded in 1995 and is hea… Read more